Biodesix (BDSX) Gains from Investment Securities (2019 - 2025)

Biodesix (BDSX) has 5 years of Gains from Investment Securities data on file, last reported at -$98000.0 in Q2 2025.

• Quarterly Gains from Investment Securities changed N/A year-over-year to -$98000.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was -$98000.0 (down 125.93% YoY) and the FY2025 annual result came in at $280000.0, changed N/A from the prior year.
• Gains from Investment Securities eased to -$98000.0 in Q2 2025, from $378000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $1.4 million in Q3 2023 to a low of -$98000.0 in Q2 2025.
• A 3-year average of $448142.9 and a median of $378000.0 in 2025 frame the typical range for Gains from Investment Securities.
• The widest YoY moves for Gains from Investment Securities: up 1083.0% in 2021, down 160.0% in 2021.
• Tracing BDSX's Gains from Investment Securities over 3 years: stood at $600000.0 in 2021, then plunged by 109.67% to -$58000.0 in 2023, then sank by 68.97% to -$98000.0 in 2025.
• The last three Gains from Investment Securities figures came in at -$98000.0 (Q2 2025), $378000.0 (Q1 2025), and -$58000.0 (Q4 2023), per Business Quant data.